Health Policy
7 articles
FDA Pilot Program Accelerates Clinical Trials for Faster Drug Approvals
The FDA is now aiming to cut up to a year from early-stage clinical trials, following a recent decision to reduce required trials for drug approval from two to one.
Federal Grant Delays Jeopardize Disability Services Research
Over $50 million in federal grants for disability services research, typically awarded by October 1st, remains unallocated as of December 1st, 2026, according to the National Council on Disability.
Researchers Removed From 2026 Diabetes Conference Amid Controversy
Northwestern associate professor Justin Ryder was among five professionals escorted out of the American Diabetes Association's 2026 annual scientific conference.
Medicare offers $50 monthly GLP-1 access amid obesity drug competition
Starting July 1, 2026, eligible Medicare beneficiaries will pay just $50 a month for certain GLP-1 obesity drugs.
House panel proposes 10% NIH raise for 2027
A House spending panel has proposed a $5 billion increase for the National Institutes of Health by fiscal year 2027, potentially reshaping medical research funding.
Phage therapy adoption hurdles: Regulatory and clinical challenges.
By 2050, antimicrobial resistance (AMR) is projected to cause 10 million deaths worldwide annually.
NIH Leadership Instability Forces Top Officials to Resign or Relocate
Eight of the top 10 officials at the U.